Compare Medpace Holdings Inc (MEDP) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Wix.Com Ltd — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Wix.Com Ltd trades at $76.56 (market cap $3.11B). The key difference: Medpace Holdings Inc is far larger — about 5.4× Wix.Com Ltd's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Wix.Com Ltd for 62 Days on average.
| MEDP | WIX | |
|---|---|---|
Market Cap | $16.82B | $3.11B |
Volume | 223,093 | 809,286 |
Sector | Health | Technology |
52-Week High | $630.19 | $145.54 |
52-Week Low | $393.42 | $40.43 |
Typical Hold Time | 14 Days | 62 Days |
Enterprise Value | $16.44B | $4.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
Wix.com (WIX) trades at $74.13, up 1.59% with mixed technical signals showing neutral overall but bullish moving averages. The company reported Q2 2026 EPS of $1.39, beating expectations, but faces negative net income margin of -8.19% despite strong revenue growth to $1.99 billion in 2025. Multiple class action lawsuits filed in September 2026 create near-term legal overhang.
Analyst consensus remains positive with 26 buy ratings and $77 price target, but investors face risks from negative cash flow trends, legal challenges, and inconsistent profitability. The stock offers growth potential if Wix can maintain revenue momentum while improving cost controls, but legal proceedings could pressure shares near-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
